These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 7866981)
1. Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer. Gao X; Zacharek A; Salkowski A; Grignon DJ; Sakr W; Porter AT; Honn KV Cancer Res; 1995 Mar; 55(5):1002-5. PubMed ID: 7866981 [TBL] [Abstract][Full Text] [Related]
2. Localization of potential tumor suppressor loci to a < 2 Mb region on chromosome 17q in human prostate cancer. Gao X; Zacharek A; Grignon DJ; Sakr W; Powell IJ; Porter AT; Honn KV Oncogene; 1995 Oct; 11(7):1241-7. PubMed ID: 7478543 [TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma. Ittmann MM Prostate; 1996 May; 28(5):275-81. PubMed ID: 8610052 [TBL] [Abstract][Full Text] [Related]
4. A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer. Tangir J; Muto MG; Berkowitz RS; Welch WR; Bell DA; Mok SC Oncogene; 1996 Feb; 12(4):735-40. PubMed ID: 8632895 [TBL] [Abstract][Full Text] [Related]
5. Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms. Futreal PA; Söderkvist P; Marks JR; Iglehart JD; Cochran C; Barrett JC; Wiseman RW Cancer Res; 1992 May; 52(9):2624-7. PubMed ID: 1568230 [TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions. Latil A; Cussenot O; Fournier G; Driouch K; Lidereau R Cancer Res; 1997 Mar; 57(6):1058-62. PubMed ID: 9067271 [TBL] [Abstract][Full Text] [Related]
7. Mutation analysis of the THRA1 gene in breast cancer: deletion/fusion of the gene to a novel sequence on 17q in the BT474 cell line. Futreal PA; Cochran C; Marks JR; Iglehart JD; Zimmerman W; Barrett JC; Wiseman RW Cancer Res; 1994 Apr; 54(7):1791-4. PubMed ID: 7511052 [TBL] [Abstract][Full Text] [Related]
8. Allelic loss of chromosome 17p, mutation of the p53 gene, and microsatellite instability in right- and left-sided colorectal cancer. Watatani M; Yoshida T; Kuroda K; Ieda S; Yasutomi M Cancer; 1996 Apr; 77(8 Suppl):1688-93. PubMed ID: 8608563 [TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Huang Y; Boynton RF; Blount PL; Silverstein RJ; Yin J; Tong Y; McDaniel TK; Newkirk C; Resau JH; Sridhara R; Reid BJ; Meltzer SJ Cancer Res; 1992 Dec; 52(23):6525-30. PubMed ID: 1423299 [TBL] [Abstract][Full Text] [Related]
10. A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus. Jacobs IJ; Smith SA; Wiseman RW; Futreal PA; Harrington T; Osborne RJ; Leech V; Molyneux A; Berchuck A; Ponder BA Cancer Res; 1993 Mar; 53(6):1218-21. PubMed ID: 8095178 [TBL] [Abstract][Full Text] [Related]
11. Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21. Vocke CD; Pozzatti RO; Bostwick DG; Florence CD; Jennings SB; Strup SE; Duray PH; Liotta LA; Emmert-Buck MR; Linehan WM Cancer Res; 1996 May; 56(10):2411-6. PubMed ID: 8625320 [TBL] [Abstract][Full Text] [Related]
12. Allelic deletion on chromosome 17p13.3 in early ovarian cancer. Phillips NJ; Ziegler MR; Radford DM; Fair KL; Steinbrueck T; Xynos FP; Donis-Keller H Cancer Res; 1996 Feb; 56(3):606-11. PubMed ID: 8564979 [TBL] [Abstract][Full Text] [Related]
13. A common deletion at chromosomal region 17q21 in sporadic prostate tumors distal to BRCA1. Dai Q; Deubler DA; Maxwell TM; Zhu XL; Cui J; Rohr LR; Stephenson RA; Brothman AR Genomics; 2001 Feb; 71(3):324-9. PubMed ID: 11170749 [TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer. Kawana Y; Ichikawa T; Suzuki H; Ueda T; Komiya A; Ichikawa Y; Furuya Y; Akakura K; Igarashi T; Ito H Prostate; 2002 Sep; 53(1):60-4. PubMed ID: 12210480 [TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity of chromosome 17 in human borderline and invasive epithelial ovarian tumors. Wertheim I; Tangir J; Muto MG; Welch WR; Berkowitz RS; Chen WY; Mok SC Oncogene; 1996 May; 12(10):2147-53. PubMed ID: 8668340 [TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer. Trapman J; Sleddens HF; van der Weiden MM; Dinjens WN; Konig JJ; Schroder FH; Faber PW; Bosman FT Cancer Res; 1994 Dec; 54(23):6061-4. PubMed ID: 7954446 [TBL] [Abstract][Full Text] [Related]
17. Evidence for a tumor suppressor gene distal to BRCA1 in prostate cancer. Williams BJ; Jones E; Zhu XL; Steele MR; Stephenson RA; Rohr LR; Brothman AR J Urol; 1996 Feb; 155(2):720-5. PubMed ID: 8558713 [TBL] [Abstract][Full Text] [Related]
18. Allelic losses at loci on chromosome 10 are associated with metastasis and progression of human prostate cancer. Komiya A; Suzuki H; Ueda T; Yatani R; Emi M; Ito H; Shimazaki J Genes Chromosomes Cancer; 1996 Dec; 17(4):245-53. PubMed ID: 8946206 [TBL] [Abstract][Full Text] [Related]